Replies to post #111958 on Sunshine Biopharma Inc (SBFM)

[hssbwwmp]

Very interesting development. If SBFM publishes updated cancer study results in October 2022 followed by a timeline (in 2023) for the Phase 1 Clinical study, that should be the needed catalyst for a sustained uptrend.

Here's the journal link to watch for the publication: https://ar.iiarjournals.org/